Effects of serum from treated patients on antibody-dependent cell adherence to the infective larvae of Brugia malayi.
Adherence assays were used to demonstrate the in vitro effect of serum-dependent cellular adherence of human buffy coat cells to infective larvae of Brugia malayi in filariasis patients treated with antifilarial drugs. In this study, microfilaraemic patients were treated with either diethylcarbamazine citrate (DEC), mebendazole or levamisole hydrochloride. It was found that DEC and mebendazole decreased the motility of infective larvae due to a direct action of the drugs. Sera of levamisole-treated patients caused increased adherence of human buffy coat cells to infective larvae, leading to a decrease in motility and cuticular damage as confirmed by scanning electron microscopic studies. However, serum of levamisole-treated patients alone could cause a similar lethal effect on infective larvae. Studies with the indirect fluorescent antibody test suggested that IgM was involved in this phenomenon. Complement did not appear to be important.
D000871:Anthelmintics / Q000627:therapeutic use*; D000906:Antibodies / Q000276:immunology*; D002009:Brugia / Q000276:immunology* / Q000502:physiology; D002448:Cell Adhesion; D003165:Complement System Proteins / Q000502:physiology; D004049:Diethylcarbamazine / Q000031:analogs & derivatives / Q000627:therapeutic use; D005368:Filariasis / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D005369:Filaricides / Q000627:therapeutic use*; D005370:Filarioidea / Q000276:immunology*; D006801:Humans; D007075:Immunoglobulin M / Q000276:immunology; D007978:Levamisole / Q000627:therapeutic use; D008214:Lymphocytes / Q000502:physiology*; D008463:Mebendazole / Q000627:therapeutic use
D000871:Anthelmintics; D000906:Antibodies; D005369:Filaricides; D007075:Immunoglobulin M; D007978:Levamisole; D008463:Mebendazole; D003165:Complement System Proteins; D004049:Diethylcarbamazine